Today's Updates

5 Rheumatology Headlines You Missed in December 2025 Victoria Johnson
Published Date: 17 Jan 2026

This rheumatology month in review emphasizes new data and impactful approvals.

Read More
Q4 2025 Recap: Rheumatology News and Updates Victoria Johnson
Published Date: 17 Jan 2026

The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.

Read More
Exploring Depressive Symptoms in Low-IQ Youth with Refractory Epilepsy Janelle L Wagner, PhD, Shannon Brothers, PhD, Cortney Wolfe-Christensen, PhD, Louie Pasculli
Published Date: 17 Jan 2026

A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.

Read More
FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease Isabella Ciccone, MPH
Published Date: 17 Jan 2026

The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.

Read More
Rituximab Displays Long-Term Effectiveness for Relapsing MS Louie Pasculli
Published Date: 17 Jan 2026

Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.

Read More
NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers Nicholas Ashton, PhD, Isabella Ciccone, MPH
Published Date: 17 Jan 2026

The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.

Read More
High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Louie Pasculli
Published Date: 17 Jan 2026

The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.

Read More
Patients Treated With REGENXBIO’s DMD Gene Therapy RGX-202 Exceed Expected Disease Trajectory on NSAA Noah Stansfield
Published Date: 17 Jan 2026

In the middle of 2026, the company is planning to submit a BLA for RGX-202 via an accelerated approval pathway.

Read More
Stereotactic Radiosurgery: Advancing Precision in Treating Neurological Disorders Lilyana Angelov, MD
Published Date: 17 Jan 2026

The director of Cleveland Clinic's Gamme Knife Center and Head Section of Spine Tumors writes about how stereotactic radiosurgery has transformed modern neurology and neurosurgery

Read More
Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations
Published Date: 17 Jan 2026

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Read More
From GOLD to Ground Level: Navigating Biologic Use in COPD Care
Published Date: 17 Jan 2026

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Read More
FDA Approves ProlivRx, First At-Home Neuromodulation Device for MDD
Published Date: 17 Jan 2026

FDA Approves ProlivRx, First At-Home Neuromodulation Device for MDD

Read More
Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk
Published Date: 17 Jan 2026

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

Read More
New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients
Published Date: 17 Jan 2026

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

Read More
Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy
Published Date: 17 Jan 2026

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

Read More
Age, Sex Specific eGFR Percentiles May Enable Earlier CKD Detection
Published Date: 17 Jan 2026

Age, Sex Specific eGFR Percentiles May Enable Earlier CKD Detection

Read More
ICP-332 Effective, Safe for Treating Moderate to Severe Atopic Dermatitis
Published Date: 17 Jan 2026

ICP-332 Effective, Safe for Treating Moderate to Severe Atopic Dermatitis

Read More
Ritlecitinib Efficacious for Non-Segmental Vitiligo Across Various Subgroups
Published Date: 17 Jan 2026

Ritlecitinib Efficacious for Non-Segmental Vitiligo Across Various Subgroups

Read More
Digital Eczema Education Decreases Relapse Rates in Children in the Short-Term
Published Date: 17 Jan 2026

Digital Eczema Education Decreases Relapse Rates in Children in the Short-Term

Read More
Unmet Needs Highlighted Regarding CSU Treatment Escalation
Published Date: 17 Jan 2026

Unmet Needs Highlighted Regarding CSU Treatment Escalation

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

2.

Cancer during young adulthood carries long-term mental toll, study finds

3.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

4.

The lack of psychiatrists may be addressed by community workers.

5.

Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image



© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot